Cardiac Flashcards

1
Q

Layers of the heart

A

Epicardium: outer layer directly covering heart
Myocardium: middle, thick mucosal layer, resoinsoble for relaxation and contraction of heart
Endocardium: inner, lies internal chamber of heart, houses capillaries, nerve fibres and heart conduction cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Serous pericardium

A
  • Parietal layer: outer layer attached to fibrous pericardium
  • Visceral layer: inner most, directly covers heart and roots of great vessels, blends with epicardium
    Between the two = pericardial cavity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Control of the heart

A

Heart rate and force is controlled by cardiac control center in the medulla
Baroreceptors in walls of aorta and internal carotid arteries detect changes in BP –> cardiac center responds through stimulation of sympathetic nervous system or parasympathetic nervous system
- SNS increases HR and contractility
PNS decreases HR and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What makes the lub dub sound

A
  • Closure of AV = lub
    ○Right side= tricuspid
    ○ Left side = bicuspid
  • Closure of semi lunar = dubb
    ○ Right side = pulmonary valve
    Left side = aortic valve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood vessel layers

A

Tunica intima: inner layer made up pf endothelial cells
Tunica media: middle layer, made up of smooth muscle that controls diameter and lumen size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Coronary circulation

A

Right and left coronary arteries - branch off aorta above aortic valve
L coronary A. divides into left ant descending and L circumflex A
Right coronary A divides into right marginal A and posterior inter ventricular A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non modifiable CVD risk factors

A
  • Gender
    • Race
    • Family history
      Age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

modifiable CVD risk factors

A
  • Hypertension
    • Hyperlipidemia
    • Diabetes
    • Obesity
    • Smoking
  • Poor diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Artherosclerosis patho

A
  1. Fatty streak formation
    i. Endothelial cells damaged –> LDL penetrate damaged epithelium and accumulate in artery wall –> inflammation
    ii. WBC activated and enter to engulf LDL and become foam cells
    iii. Foam cells cluster together and form fatty streaks
    2. Atheroma/plaque formation
    i. Fatty streak grows as more cholesterol, lips and inflamatory cells accumulate
    ii. Smooth muscle cells migrate from deeper levels to repair fatty streak–> form fibrous cap over the lipids
    3. Plaque rupture and complications
    i. Continued inflammation weakens the cap, if it ruptures the contents are exposed to the blood stream forming a blood clot (thrombus) at the site
    ii. Clot can partially or fully obstruct the artery –> myocardial Infarction, stroke or peripheral artery
    Can break off and travel within the body (when thrombus breaks off it is called an embolus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atherosclerosis etiology

A

○ Modifiable and non modifiable
- Smoking, sedentary lifestyle, diabetes, Obesity, high fat diet elevate serum lipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atherosclerosis clinical features

A

○ Initially asymptomatic
○ Ischemia in affected tissue
○ Depends on location
§ Coronary artery - angina, MI
§ Carotid artery - TIA or stroke
Peripheral artery - aneurysm, peripheral artery diseas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Atherosclerosis treatment

A

○ Slow disease progression
○ Diet changes, 150m exercise, smoking cessation
○ Weight and stress management
○ Pharmacological
§ Lipid lowering therapy
§ Antiplatelet to reduce clot formation
○ Control primary disorder
○ Surgical intervention if there is advanced obstruction
§ Ballon angioplasty
Enterectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Complications of atherosclerosis

A

Angina, MI, aneurysm, peripheral vascular disease, transient ischemic attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Peripheral artery disease

A

narrowed peripheral arteries reduce blood flow to arms or legs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PAD patho and risk factors

A

as per atherosclerosis (obstruction in peripheral artery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PAD clinical features

A

Lower extremity pain due to ischemia
○ Claudication: leg pain associated with exertion due to muscle ischemia, initally resolves with rest but may not once advanced
- Non healing wounds/ulcers: due to blood supply (often in foot)
- Skin discoloration/gangrene
○ Initially color discoloration and can progress to necrosis
○ Dry shiny hairless skin
○ Skin temp reduced due to reduced blood flow
- Decreased pulses
- Sensory loss (generally distal or proximal, “glove and stocking distribution”)
- Fatigue and weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PAD diagnosis

A
  • Ankle brachial measure
    Doppler (reduced blood flow and pulses)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PAD treatment

A
  • Prevention (smoking cessation, BP control, activity)
    • Goals: slow progression of atherosclerosis, maintain lower limb circulation, treat complications
    • Education to avoid skin trauma, regular exam to avoid pressure areas
    • Medication to improve peripheral vasodilation and improve perfusion to limbs
    • Surgery
      ○ Bypass reduction
      ○ Debride ulcers
      Amputation if dangerous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hypertension stage 1 and 2

A
  • Stage 1: 130-139/80-85
    Stage 2: 140/90 or above
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hypertension patho

A
  • 3 major categories
    ○ Primary: idiopathic (BP> 140/90)
    ○ Secondary: from other pathology (renal or endocrine disease)
    ○ Malignant/resistant HTN: difficult to control (needs over 3 antihypertension drugs)
    • Increased arteriole vasoconstriction due to increased peripheral resistance, reduces system capacity and increases afterload
    • Decreased blood flow through kidney, secrete renin, angiotensin and aldosterone which causes more vasoconstriction –> further BP increase
    • Increased BP will cause damage to blood vessels
      thickened walls, narrowing lumen, dilation or tea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hypertension etiology

A
  • Age
    • Men more
    • Genetics (African American, family)
    • High sodium
    • Obesity
      Prolonged or recurrent stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypertension clinical features

A
  • Asymptomatic early on and vague symptoms
    Fatigue, malaise, morning headache
23
Q

Hypertension diagnosis

A

at least 2 of the following

○ 24hr mean BP SBP ≥ 125 or DBP ≥ 75
○ Daytime mean SBP ≥ 130 or DBP ≥80
Nighttime mean SBP ≥ 110 or DBP ≥80

24
Q

Hypertension treatment

A
  • Non pharmacological
    ○ Salt restriction, potassium supplementation, weight loss, DASH diet, limit alcohol
    ○ Exercise 3-4x weekly
    ○ Stress management
  • Pharmacological
    Antihypertensive (usually in stage 2)
25
Q

Hypertension complications

A

○ Left ventricular hypertrophy
○ Heart failure
○ Ischemic stroke
○ MI
Chronic kidney failure

26
Q

Aortic Aneurysm patho

A
  • Most common in thoracic or abdominal aorta
    • Multifactorial systemic process caused by alterations in vascular wall –> loss of wall strength and defect in middle layer of vessel
      ○ Due to inflammation, protein breakdown and genetics
    • Dilation can enlarge overtime
    • Thrombus may also form in the dilated area and become an embolus
    • Can rupture and cause a hemorrhage
    • Different shapes
      ○ Fusiform - circumferential dilation
      ○ Saccular - bulging wall on 1 side
      Dissecting - tear in intima, allow blood to flow along length of vessel between layers of arterial wall
27
Q

Aneurysm etiology

A
  • Risk: atherosclerosis, smoke, age, male, family, HTN
    • Trauma
    • Infection (e.g. syphilis, HIV)
      Congenital (e.g. connective tissue disease)
28
Q

Aortic aneurysm clinical features

A
  • Asymptomatic until rupture
    • Symptomatic but not ruptured
      ○ Abdominal, back or flank pain
      ○ Fever or malaise
      ○ Pulsatile abdominal mass
      ○ Can compress other structures (e.g. esophagus)
    • Symptomatic and ruptured
      ○ Severe pain, hypotension, pulsatile abdominal mass (~50% of cases)
      Critical to see immediate medical attention
29
Q

Aortic aneurysm diagnosis

A
  • Asymptomatic via incidental finding
    Symptomatic (US, CT, MRI)
30
Q

Aortic aneurysm treatment

A
  • Manage based on diameter and presence of symptoms
    ○ Asymptomatic and small (<5.5cm) –> conservative management
    ○ Asymptotic and large (>5.5cm) elective surgical repair via AAA repair
    • Surgery
      ○ Open graft
      Endovascular repair
31
Q

Acute coronary syndrome

A

Umbrella term for a range of conditions related to sudden, reduced blood flow to the heart
- Angina pectoris
Myocardial infarction

32
Q

Angina patho

A
  • Myocardial oxygen demands exceed O2 supply
    ○ Most often when there is a sudden O2 demand increase (e.g. exertion)
    • Vessels are damaged so cannot vasodilate to meet blood supply demand
    • Reduced supply can be due to:
      ○ Partial obstruction of a coronary artery
      ○ Spasm in coronary artery
    • May lead to myocardial infarction
      No damage unless they are frequent, prolonged or severe
33
Q

Angina etiology

A
  • Insufficient myocardial blood flow is associated with atherosclerosis, arteriosclerosis, vasospasm and myocardial hypertrophy
    • Severe anemia and respiratory disease can cause oxygen deficit
      Exertion
34
Q

Angina clinical features

A
  • Chest pain
    • Pressure or heaviness
    • Tightness, squeezing, constriction in center or left of chest
      Caused by exertion and made better my rest
35
Q

Angina diagnosis and treatment

A

Diagnosis: based on symptoms
Treatment
- Goal: relieve symptoms, prevent future cardiac events
- Prevention: beta blockers, calcium channel blockers, long acting nitrates
- Acute symptom management
○ Nitroglycerin (reduces systemic resistance and vasospasms)
○ Antiplatelet
○ Reduce exasperating factors (e.g. underlying disease or rest)
Regular follow up every 6-12 months

36
Q

Myocardial infarction patho

A
  • MI (heart attack) occurs when blood flow is fully obstructed due to atherosclerosis in one or more arteries leading to ischemia and cell death in the heart wall
    • Most involve all layers of the heart
    • Most often involve left ventricles (contracts against higher resistance)
    • At location of obstruction, heart becomes necrotic and area of injury, inflammation and ischemia develop around it and cardiac enzymes are released
    • Myocardial contractility and conduction are lost once O2 is depleted
    • If blood supply can be restored in 20-30min, may prevent damage
    • Myocardial fibres do not regenerate and fibrous tissue develops around the area of necrosis creating a scar
      Collateral circulation may reduce size of infarct
37
Q

MI etiology

A
  • Most common cause is atherosclerosis, usually with thrombus
    • Infarction can develop 3 ways
      ○ Thrombus can build and obstruct and block artery
      ○ Vasospasm can occur in presence of partial obstruction by atheroma/plaque leading to total obstruction
      Part of thrombus can break free and the emboli can flow through the coronary artery blocking i
38
Q

MI diagnosis

A
  • ECG changes
    ○ STEMI - ST elevation (generally full occlusion)
    ○ NSTEMI - non ST elevation (often smaller artery)
    • Nuclear imaging
    • Presence of enzymes, factors and electrolytes in blood test
      ○ Increase in myosin and troponin
      ○ Increased serum levels
      ○ Abnormal potassium and sodium
      Increased inflammatory markers
39
Q

MI clinical features

A
  • Pain
    • Men
      ○ Sudden substernal chest pain radiating into left arm, shoulder, jaw, neck or back
    • Women
      ○ Jaw, neck or upper back pain
      ○ Pain or pressure in lower chest or upper abdomen (often interpreted as indigestion)
      ○ Extreme fatigue, fainting
    • Pallor, diaphoresis (sweating), nausea, weakness, dyspnea
    • Anxiety/fear
    • Hypotension
    • Rapid, weak pule as CO decreases
      Low grade fever
40
Q

MI treatment

A
  • Goals: reduce risk of death and extent of permanent injury
    • Symptom management
      ○ Angina: nitroglycerin and antihypertensives +/- diuretics to reduce BP and O2 demand
      ○ Pain relief
    • Reperfusion
      ○ Antithrombotic therapy
      ○ Angioplasty to restore blood flow + stent
      ○ Coronary artery bypass surgery
    • Lifestyle modification
      Smoking cessation, exercise, nutrition, weight management, managing chronic disease
41
Q

Heart failure patho

A
  • Any structural or functional cardiac disorders that impair the ability of ventricles to fill with or eject blood
    • Left and right HF can occur together or separately
      ○ Left HR often causes right HF
      ○ E.g. pulmonary valve stenosis affects right side first vs MI in left ventricle affects right ventricle first
    • CO decreases initially –> compensatory Mx
      ○ Increased SN drive –> increased vasoconstriction and increased resistance of left ventricle –> increased HR and force
      ○ Decreased blood flow to kidney–> renin secretion –> vasoconstriction –> aldosterone stimulation –> Na and H2O retention –> increased blood volume
    • While CO is maintained, peripheral resistance and afterload are increased –> increased workload for the heart
    • Increased HR –> decreased filling
    • Heart remodels to adapt but reaches a limit with time –> heart failure
      Inability to maintain pumping capacity –> CO or SV decrease –> less blood reaches organs/tissues –> decreased cell function –> fatigue, lethargy, mild acidosis and increased RR
42
Q

RHF vs LHF

A

Left side heart failure:
Left ventricle cannot pump all blood into systemic circulation (decreased CO) so normal blood volume returning from lungs cant enter the left heart –> backup of fluid into the lungs –> pulmonary congestion and increased capillary pressure –> pulmonary edema

Right side HF:
Right ventricle cannot maintain output (decreased CO) so less blood is getting into circulation –> systemic circulation back up–> systemic congestion returning to heart –> increased blood volume in legs, feet and abdomen

43
Q

HF etiology

A
  • LHF cause: LV infarct, aortic valve stenosis, HTN
    RHF: RV infarct, pulmonary valve stenosis, pulmonary disease
44
Q

HF clinical features

A
  • Either side
    ○ Hypoxia, fatigue, weakness, dyspnea, decreased exercise tolerance, cold intolerance, dizziness
  • LHF
    ○ Dyspnea, orthopnea as pulmonary edema develops, frothy sputum
    ○ Coughing due to fluid irritating respiratory passages
    ○ Paroxysmal nocturnal dyspnea due to acute pulmonary edema
    ○ Decreased exercise tolerance
  • RHF
    ○ Edema in feet or legs, increases JVO
    ○ Hepatomegaly and splenomegaly –> digestive issues
    ○ Ascites - fluid in peritoneal cavity as fluid accumulates, can cause abdominal distension and impair lung expansion
    Flushed face, distended neck, headache, visual disturbance
45
Q

HF classification

A
  • Ejection fraction
    ○ HF with LV ejection fraction <40% = HF with reduced ejection fraction
    ○ HF with LVEF 41%-49% = HF with mid range ejection fraction
    HF with LVEF >50% = HF with preserved ejection fraction
46
Q

HF classes

A

1 = no limitation in PA
2 = slight limitation with PA, fine at rest
3 = marked limitation with PA, fine at rest. Less than ordinary intesity causes fatigue, SOB
4 = symptoms at rest

47
Q

HF diagnosis

A
  • Based on history, physical exam, labs and imagining
    • Gold standard: identifying elevated pulmonary capillary wedge pressure at rest with left pulmonary artery catheter
      Results can indicate whether a patient can mobilize or not
48
Q

HF treatment

A
  • Treat underlying problem
    • Reduce workload on heart by avoiding excessive fatigue, stress, sudden exertion
    • Meds
      ○ ACE inhibitors for vasodilation
      ○ Digoxin - improves cardiac efficiency
      ○ Antihypertensives and vasodilators to reduced BP
      Diuretics to reduce fluid accumulation
49
Q

CVD and stroke

A
  • Overlapping risk factors
    • Likely have blockages in arteries including carotid
    • Can lead to 2 kinds of ischemic stroke
      ○ Atherothrombotic: plaque reduces blood flow to brain (major stroke)
      Embolic - plaque breaks from primary site and travels to brain where it lodges in artery
50
Q

CVD and osteoporosis

A
  • Shared risk factors
    ○ Smoking, reduced activity, alcohol, hypertension (all which can promote atherosclerosis and bone demineralization)
    • Common pathophysiological mechanisms
      ○ Inflamatory markers and cytokines
      ○ Endogenous sex hormones (estrogen deficiency) - estrogen has protective effect on CV system
    • Common genetic factors
      ○ Some genes are associated with both BMD loss and atherogenesis
    • Causal association
      Atherosclerosis –> decreased blood flow to lower extremities –> decreased intraosseous blood circulation –> altered metabolism
51
Q

Type 2 diabetes and stroke

A
  • CVD is most. Prevalent cause of mortality in diabetes patients
    • Diabetes patients often have many risk factors for developing CVD
      ○ HTN
      ○ Abnormal cholesterol and high tryglycerides
      ○ Obesity
      ○ Poorly controlled sugars
      Lack of activty
52
Q

COPD and HF

A
  • COPD –> hypoxia –> pulmonary arteries constrict –> increased pulmonary vascular resistance
    • Increased resistance –> pulmonary hypertension –> Right ventricle must pump against higher pressure and overtime will hypertrophy –> dilation and failure due to reduced contractile efficiency
    • RHF develops –>
      ○ Peripheral edema
      ○ Jugular venous distension
      ○ Hepatomegaly
      ○ Ascites
      HF impact on COPD
    • LHF –>pulmonary congestion –> worse dyspnea
      Reduced CO –> less O2 to respiratory muscle –>. Respiratory fatigue
53
Q

Physio management

A

General goals
- Improve CV endurance and functional capacity
- Reduce dyspnea and fatigue
- Lifestyle modifications
- Self monitoring and symptom recognition
- Improve QOL
Acute
- Mobility and function
- Education (lifestyle, smoking, exercise)
Sub acute
- Outpatient cardiac rehab
Transition to maintenance and self monitoring

54
Q

Cardiac rehab

A

Structured multidisciplinary approach to support patient with MI, heart failure or cardiac surgery
Goal: improve cardiac health, reduce risk of future cardiac events, enhance QOL
Includes
- Initial evaluation
○ Cardiac assessment
○ Functional capacity testing (6MWT)
○ Medical history and risk factor assessment
- Supervised exercise
○ Aerobic
○ Resistance
○ Intervals (later)
○ Flexibility and balance
- FITT: 5x week, 50-70% Max HR, 20-60min, aerobic
- Education and lifestyle modification